ADME/TK Evaluation (S0852) of 5-Amino-o-cresol (2835-95-2) in F344 Rats and B6C3F1 Mice Exposed via Gavage Administration, Intravenous Injection or Dermal Application
Radiolabel Description:
Carbon-14 uniformly in the ring; 5-Amino-o-cresol, [ring-14C(U)]-
Vehicles:
Intravenous, ethanol:Alkmuls:water (1:1:8); Dermal, ethanol.
Summary Data - Female Rats
- Dermal Single Dose (2 mg/kg Covered, Study Duration 24 hours) (49KB)
- Dermal Single Dose (2 mg/kg Uncovered, Study Duration 24 hours) (49KB)
- Dermal Single Dose (20 mg/kg Covered, Study Duration 72 hours) (52KB)
- Dermal Single Dose (20 mg/kg Uncovered, Study Duration 24 hours) (57KB)
- Dermal Single Dose (20 mg/kg Uncovered, Study Duration 72 hours) (51KB)
- Gavage Single Dose (3.5 mg/kg, Study Duration 24 hours) (45KB)
- Gavage Single Dose (35 mg/kg, Study Duration 24 hours) (45KB)
- Gavage Single Dose (350 mg/kg, Study Duration 24 hours) (43KB)
- IV Single Dose (3.5 mg/kg, Study Duration 24 hours) (46KB)